Anti-HIV activity in vitro of MGN-3, an activated arabinoxylane from rice bran

被引:71
作者
Ghoneum, M [1 ]
机构
[1] Charles R Drew Univ Med & Sci, Dept Otolaryngol, Los Angeles, CA 90059 USA
关键词
D O I
10.1006/bbrc.1997.8047
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MGN-3, an arabinoxylane from rice bran that has been enzymatically modified with extract from Hyphomycetes mycelia, was tested for anti-HIV activity in vitro. MGN-3 activity against HIV-1 (SF strain) was examined in primary cultures of peripheral blood mono-nuclear cells, MGN-3 inhibited HIV-I replication by: (1) inhibition of HIV-1 p24 antigen production in a dose dependent manner-MGN-3 at concentrations of 12.5, 25, 50, and 100 mu g/ml showed 18.3, 42.8, 59, and 75% reduction in p24 antigen, respectively; and (2) inhibition of syncytia formation maximized (75%) at concentrations of 100 mu g/ml. Further studies showed that ingestion of MGN-3 at concentration of 15 mg/kg/day resulted in a significant increase in T and B cell mitogen response at 2 months after treatment: 146% for PHA, 140% for Con A, and 136.6% for PWM. mitogen. We conclude that MGN-3 possesses potent anti-HIV activity and in the absence of any notable side effects, MGN-3 shows promise as an agent for treating patients with AIDS. (C) 1998 Academic Press.
引用
收藏
页码:25 / 29
页数:5
相关论文
共 16 条
[1]   ZIDOVUDINE SENSITIVITY OF HUMAN IMMUNODEFICIENCY VIRUSES FROM HIGH-RISK, SYMPTOM-FREE INDIVIDUALS DURING THERAPY [J].
BOUCHER, CAB ;
TERSMETTE, M ;
LANGE, JMA ;
KELLAM, P ;
DEGOEDE, REY ;
MULDER, JW ;
DARBY, G ;
GOUDSMIT, J ;
LARDER, BA .
LANCET, 1990, 336 (8715) :585-590
[2]  
Ghoneum M, 1996, 87 ANN M AM ASS CANC
[3]  
GHONEUM M, 1995, ABSTR CANC INT BAS A
[4]  
GHONEUM M, 1996, FASEB J AM SOC BIOCH
[5]   ISOLATION OF A PREVIOUSLY UNIDENTIFIED POLYSACCHARIDE (MAR-10) FROM HYSSOP OFFICINALIS THAT EXHIBITS STRONG ACTIVITY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
GOLLAPUDI, S ;
SHARMA, HA ;
AGGARWAL, S ;
BYERS, LD ;
ENSLEY, HE ;
GUPTA, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 210 (01) :145-151
[6]  
HARRMANN EC, 1967, P EX BIOL MED, V124, P874
[7]   PREVALENCE AND CLINICAL-SIGNIFICANCE OF ZIDOVUDINE RESISTANCE MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATED FROM PATIENTS AFTER LONG-TERM ZIDOVUDINE TREATMENT [J].
JAPOUR, AJ ;
WELLES, S ;
DAQUILA, RT ;
JOHNSON, VA ;
RICHMAN, DD ;
COOMBS, RW ;
REICHELDERFER, PS ;
KAHN, JO ;
CRUMPACKER, CS ;
KURITZKES, DR .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) :1172-1179
[8]  
JOHNSON VA, 1990, TECHNIQUES HIV RES, P92
[9]   ANTIVIRAL ACTIVITIES OF EXTRACTS OF LEMON BALM PLANT [J].
KUCERA, LS ;
COHEN, RA ;
HERRMANN, EC .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1965, 130 (A1) :474-+
[10]   MODIFICATION OF HUMAN IMMUNODEFICIENCY VIRAL REPLICATION BY PINE CONE EXTRACTS [J].
LAI, PK ;
DONOVAN, J ;
TAKAYAMA, H ;
SAKAGAMI, H ;
TANAKA, A ;
KONNO, K ;
NONOYAMA, M .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (02) :205-217